Clinical Trial Update: Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update noting completion of a study evaluating spermatogenesis in men with sickle cell disease who are being treated with hydroxyurea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Drepanocytic Men Treated by Hydroxyurea for the First Time | Phase 4 | Status: COMPLETED